logo
logo

Inscripta® Acquires Infinome Biosciences And Sestina Bio To Advance Sustainable Biomanufacturing

Jan 18, 2023•over 2 years ago

Acquiring Company

Inscripta

Acquired Company

BIOSCIENCES

BoulderBiotechnologyManufacturing

Description

Inscripta, a global leader in genome engineering technology, announced today the acquisition of two pioneers of synthetic biology – Infinome Biosciences and Sestina Bio, which advance Inscripta's strategy to develop and commercialize bio-manufactured products for a broad spectrum of industrial and consumer markets.

Company Information

Company

Inscripta

Location

Boulder, Colorado, United States

About

Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Sri hidden

hidden

Ron hidden

hidden
hidden